BMS’ Orencia Autoinjector Hits the Market

Bristol-Myers Squibb announced Wednesday it has released its new autoinjector Orencia for adults with moderate to severe rheumatoid arthritis.

Orencia comes in three different forms: IV infusion, prefilled syringe and autoinjector.

The device is indicated for reducing the signs and symptoms of RA, deterring the advancement of structural damage due to the condition, and improving mobility. — Cynthia Jessup